Can-Fite (CANF) Enters Pact with Hadassah Medical Center to Further Explore Namodenoson Mechanism of Action in NASH
Tweet Send to a Friend
Can-Fite BioPharma Ltd. (NYSE: CANF) today announced the entry into a collaborative research agreement with Hadassah Medical School. This agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
